HCRN Directory

Anal

BTCRC-GI22-588

A Phase II Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

Status

Cancer Types

Anal

Locations

Rutgers Cancer Institute, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Wisconsin Carbone Cancer Center